09.06.24 -- Drug Product Formulation & Process Development: The Must-Have Skills At A Glance

Utilizing tape for positioning during Sterilize in Place (SIP) validation can introduce numerous issues. Explore the top eight reasons why tape should be avoided during SIP validation cycles.

Here, we will analyze and explain different containment methods and help determine which would be most beneficial for your first (or next) containment device to ensure personnel protection.

Drug development is a long and complex process, and every step has specific goals. Examine the relevant objectives and techniques used in each stage of antibody drug development.

Learn how one environmental monitoring system provided seamless and continuous cleanroom monitoring and control during the major global IT outages due to the CrowdStrike incident.

Explore the challenges of producing painkillers with abuse-deterrent formulations, tips for minimizing risk during HPAPI manufacture, and how to plan for successful technology transfer.

With the use of advanced in vitro models like Organ-Chips, researchers are gaining a better understanding of CAR T-cell therapy in the context of solid tumors.

Discover the key features of an innovative microbial compressed gas air sampler, designed for the user's peace of mind, ease of use, maximum safety, and full regulatory compliance.

The delivery of this mobile cGMP cleanroom facility to ACT showcases one company's commitment to providing innovative solutions that meet clients' unique needs and contribute to advancing healthcare.

Precision powder microdosing makes it possible to quickly get formulations to the clinic, saving time, money, and use of limited APIs.

With increased pressure on CMC development to support shortened BLA submission timelines, mass spectrometry (MS) can be leveraged to accelerate and de-risk product and process development.

Often, a complication of feeding and batching is charging tanks/reactors of different heights and configurations. Discover a highly accurate feeding solution that can be moved from mixer to mixer.

When drug and API manufacturers decide to make the shift to bring production back to the U.S., they should be prepared with a well-designed quality system and a thorough tech transfer process.